Aardvark Therapeutics Inc (AARD) PT Lowered to $18 at RBC Capital
Tweet Send to a Friend
RBC Capital analyst Brian Abrahams lowered the price target on Aardvark Therapeutics Inc (NASDAQ: AARD) to $18.00 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
